A recent study reported the mutation of an oligodendrocyte-related transcription factor TCF12 in 7.5% of anaplastic oligodendrogliomas: the mutations compromise TCF12 transcriptional activity and are associated with an aggressive tumor phenotype [148]. This evidence concerns the gene TCF12 and neoplasm.